Using Engineered Bacteria to Characterize Infection Dynamics and Antibiotic Effects In Vivo

Cell Host and Microbe

Volumn 22, Issue 3, 2017, Pages 263-268.e4

  Certain, Laura K ^a,b   Way, Jeffrey C ^a   Pezone, Matthew J ^a   Collins, James J ^a,c,d,e  

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Massachusetts Institute of Technology   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

chronic infection; genetic toggle switch; synthetic biology

Indexed keywords

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CELL DIVISION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; DYNAMICS; ESCHERICHIA COLI; IN VITRO STUDY; IN VIVO STUDY; MICROBIAL POPULATION DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SYNTHETIC BIOLOGY; ANIMAL; DISEASE MODEL; DRUG EFFECT; ESCHERICHIA COLI INFECTION; GENETIC ENGINEERING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIOLOGY; MOUSE;

ANTIINFECTIVE AGENT;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETIC ENGINEERING; HUMANS; MICE;

EID: 85028502175     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2017.08.001     Document Type: Article

References (39)

1. Ackers, G.K., Johnson, A.D., Shea, M.A., Quantitative model for gene regulation by lambda phage repressor. Proc. Natl. Acad. Sci. USA 79 (1982), 1129–1133.
2. Allison, K.R., Brynildsen, M.P., Collins, J.J., Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473 (2011), 216–220.
3. Archer, N.K., Mazaitis, M.J., Costerton, J.W., Leid, J.G., Powers, M.E., Shirtliff, M.E., Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2 (2011), 445–459.
4. Bachmanov, A.A., Reed, D.R., Beauchamp, G.K., Tordoff, M.G., Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav. Genet. 32 (2002), 435–443.
5. Bernthal, N.M., Stavrakis, A.I., Billi, F., Cho, J.S., Kremen, T.J., Simon, S.I., Cheung, A.L., Finerman, G.A., Lieberman, J.R., Adams, J.S., Miller, L.S., A mouse model of post-arthroplasty Staphylococcus aureus joint infection to evaluate in vivo the efficacy of antimicrobial implant coatings. PLoS One, 5, 2010, e12580.
6. Braff, D., Shis, D., Collins, J.J., Synthetic biology platform technologies for antimicrobial applications. Adv. Drug Deliv. Rev. 105:Pt A (2016), 35–43.
7. Claudi, B., Spröte, P., Chirkova, A., Personnic, N., Zankl, J., Schürmann, N., Schmidt, A., Bumann, D., Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell 158 (2014), 722–733.
8. Cohen, N.R., Lobritz, M.A., Collins, J.J., Microbial persistence and the road to drug resistance. Cell Host Microbe 13 (2013), 632–642.
9. Conlon, B.P., Rowe, S.E., Gandt, A.B., Nuxoll, A.S., Donegan, N.P., Zalis, E.A., Clair, G., Adkins, J.N., Cheung, A.L., Lewis, K., Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat. Microbiol., 1, 2016, 16051.
10. Daeffler, K.N., Galley, J.D., Sheth, R.U., Ortiz-Velez, L.C., Bibb, C.O., Shroyer, N.F., Britton, R.A., Tabor, J.J., Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation. Mol. Syst. Biol., 13, 2017, 923.
11. Danino, T., Prindle, A., Kwong, G.A., Skalak, M., Li, H., Allen, K., Hasty, J., Bhatia, S.N., Programmable probiotics for detection of cancer in urine. Sci. Transl. Med., 7, 2015, 289ra84.
12. Friedland, A.E., Lu, T.K., Wang, X., Shi, D., Church, G., Collins, J.J., Synthetic gene networks that count. Science 324 (2009), 1199–1202.
13. Gardner, T.S., Cantor, C.R., Collins, J.J., Construction of a genetic toggle switch in Escherichia coli. Nature 403 (2000), 339–342.
14. Gottesman, S., Proteolysis in bacterial regulatory circuits. Annu. Rev. Cell Dev. Biol. 19 (2003), 565–587.
15. Grant, S.S., Hung, D.T., Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Virulence 4 (2013), 273–283.
16. Helaine, S., Cheverton, A.M., Watson, K.G., Faure, L.M., Matthews, S.A., Holden, D.W., Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343 (2014), 204–208.
17. Hwang, I.Y., Koh, E., Wong, A., March, J.C., Bentley, W.E., Lee, Y.S., Chang, M.W., Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nat. Commun., 8, 2017, 15028.
18. Kalinka, J., Hachmeister, M., Geraci, J., Sordelli, D., Hansen, U., Niemann, S., Oetermann, S., Peters, G., Löffler, B., Tuchscherr, L., Staphylococcus aureus isolates from chronic osteomyelitis are characterized by high host cell invasion and intracellular adaptation, but still induce inflammation. Int. J. Med. Microbiol. 304 (2014), 1038–1049.
19. Kobayashi, H., Kaern, M., Araki, M., Chung, K., Gardner, T.S., Cantor, C.R., Collins, J.J., Programmable cells: interfacing natural and engineered gene networks. Proc. Natl. Acad. Sci. USA 101 (2004), 8414–8419.
20. Kojima, R., Aubel, D., Fussenegger, M., Toward a world of theranostic medication: programming biological sentinel systems for therapeutic intervention. Adv. Drug Deliv. Rev. 105:Pt A (2016), 66–76.
21. Kotula, J.W., Kerns, S.J., Shaket, L.A., Siraj, L., Collins, J.J., Way, J.C., Silver, P.A., Programmable bacteria detect and record an environmental signal in the mammalian gut. Proc. Natl. Acad. Sci. USA 111 (2014), 4838–4843.
22. Lee, H.H., Molla, M.N., Cantor, C.R., Collins, J.J., Bacterial charity work leads to population-wide resistance. Nature 467 (2010), 82–85.
23. Lee, J.W., Gyorgy, A., Cameron, D.E., Pyenson, N., Choi, K.R., Way, J.C., Silver, P.A., Del Vecchio, D., Collins, J.J., Creating single-copy genetic circuits. Mol. Cell 63 (2016), 329–336.
24. Ling, L.L., Schneider, T., Peoples, A.J., Spoering, A.L., Engels, I., Conlon, B.P., Mueller, A., Schäberle, T.F., Hughes, D.E., Epstein, S., et al. A new antibiotic kills pathogens without detectable resistance. Nature 517 (2015), 455–459.
25. Loessner, H., Leschner, S., Endmann, A., Westphal, K., Wolf, K., Kochruebe, K., Miloud, T., Altenbuchner, J., Weiss, S., Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect. 11 (2009), 1097–1105.
26. Löffler, B., Tuchscherr, L., Niemann, S., Peters, G., Staphylococcus aureus persistence in non-professional phagocytes. Int. J. Med. Microbiol. 304 (2014), 170–176.
27. Manina, G., Dhar, N., McKinney, J.D., Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms. Cell Host Microbe 17 (2015), 32–46.
28. Marx, J.O., Vudathala, D., Murphy, L., Rankin, S., Hankenson, F.C., Antibiotic administration in the drinking water of mice. J. Am. Assoc. Lab. Anim. Sci. 53 (2014), 301–306.
29. Osmon, D.R., Berbari, E.F., Berendt, A.R., Lew, D., Zimmerli, W., Steckelberg, J.M., Rao, N., Hanssen, A., Wilson, W.R., Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 56 (2013), e1–e25.
30. Pakula, A.A., Young, V.B., Sauer, R.T., Bacteriophage lambda cro mutations: effects on activity and intracellular degradation. Proc. Natl. Acad. Sci. USA 83 (1986), 8829–8833.
31. Riglar, D.T., Giessen, T.W., Baym, M., Kerns, S.J., Niederhuber, M.J., Bronson, R.T., Kotula, J.W., Gerber, G.K., Way, J.C., Silver, P.A., Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation. Nat. Biotechnol. 35 (2017), 653–658.
32. Saliba, A.E., Li, L., Westermann, A.J., Appenzeller, S., Stapels, D.A., Schulte, L.N., Helaine, S., Vogel, J., Single-cell RNA-seq ties macrophage polarization to growth rate of intracellular Salmonella. Nat. Microbiol., 2, 2016, 16206.
33. Shea, M.A., Ackers, G.K., The OR control system of bacteriophage lambda. A physical-chemical model for gene regulation. J. Mol. Biol. 181 (1985), 211–230.
34. Slomovic, S., Pardee, K., Collins, J.J., Synthetic biology devices for in vitro and in vivo diagnostics. Proc. Natl. Acad. Sci. USA 112 (2015), 14429–14435.
35. Tande, A.J., Patel, R., Prosthetic joint infection. Clin. Microbiol. Rev. 27 (2014), 302–345.
36. Tuchscherr, L., Kreis, C.A., Hoerr, V., Flint, L., Hachmeister, M., Geraci, J., Bremer-Streck, S., Kiehntopf, M., Medina, E., Kribus, M., et al. Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis. J. Antimicrob. Chemother. 71 (2016), 438–448.
37. Wiegand, I., Hilpert, K., Hancock, R.E., Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3 (2008), 163–175.
38. Zeiler, H.J., Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth. Antimicrob. Agents Chemother. 28 (1985), 524–527.
39. Zmistowski, B., Fedorka, C.J., Sheehan, E., Deirmengian, G., Austin, M.S., Parvizi, J., Prosthetic joint infection caused by gram-negative organisms. J. Arthroplasty 26:6 Suppl (2011), 104–108.